NCT03818243

Brief Summary

Investigator have recently shown that Parkinson disease patients' with restless leg Syndrome have more frequent impulse control behavior in particular compulsive feeding that patients without Restless Leg Syndrome (RLS). Investigator hypothesized that presence of RLS in parkinsonian patients could be a risk factor for the emergence of TCI or associated behaviors, occurring preferentially at night. The main objective of this study is to evaluate in patients with idiopathic Parkinson's disease (IPD) the effect of the presence of a RLS on the evening compulsive eating behavior by studying the circadian modulation of food intake of patients with RLS and impulse control disorders. For this investigator conduct a prospective study, with 2 groups of Parkinson disease patients (with and without restless leg syndrome), to which investigator have to fill an agenda to know the schedule of the behaviors during the day and the night.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 21, 2019

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 28, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2023

Completed
Last Updated

July 10, 2023

Status Verified

July 1, 2023

Enrollment Period

3.4 years

First QC Date

January 24, 2019

Last Update Submit

July 7, 2023

Conditions

Keywords

Parkinson diseaseRestless Leg SyndromeImpulse control disorderscircadian rhythm

Outcome Measures

Primary Outcomes (1)

  • The percentage of daily night food intake measured at baseline + 15 day using the diary.

    at baseline + 15 day

Secondary Outcomes (6)

  • Percentage of night behavior for the other impulse control disorders , measured at baseline + 15 day using the diary

    at baseline + 15 day

  • Percentage of patients with compulsive food intake measured at baseline + 15 day

    at baseline + 15 day

  • Percentage of patients with others impulse control disorders or other associated behavior measured at baseline + 15 day

    at baseline + 15 day

  • Percentage of patients with the night eating syndrome using the Night Eating Questionnaire measured at baseline + 15 days

    at baseline + 15 day

  • Percentage of patients with Sleep related eating disorders using the International classification of sleep disorders-third edition criteria measured at baseline + 15 days

    at baseline + 15 day

  • +1 more secondary outcomes

Study Arms (2)

RLS-

EXPERIMENTAL

patients with Parkinson disease without RLS

Behavioral: Diary (for reporting all impulse control disorders especially compulsive eating disorders)

RLS+

EXPERIMENTAL

patients with Parkinson disease with RLS

Behavioral: Diary (for reporting all impulse control disorders especially compulsive eating disorders)

Interventions

During 7 days, at home, patients must report in their diary all their impulse control disorders especially their compulsive eating disorders. They will detailed each food intake and drink intake and the time.

RLS+RLS-

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men or women, 18 to 80 years
  • Patients with a Parkinson disease (PD) with UKPDSBB criteria
  • Social security affiliation
  • Acceptance of the protocol and signature of a written consent
  • RLS group: Patients with IRLSSG criteria of RLS, with a frequency of RLS ≥ 2 times per week Group without RLS: Patients without IRLSSG criteria of RLS

You may not qualify if:

  • Patients with an other neurological disease than Parkinson's disease
  • Patients with secondary RLS (other than Parkinson's disease)
  • Patients with psychiatric diseases
  • Patients with cognitive disorder (MoCA \<21)
  • Patients with body mass index \<16.5 or \>30
  • Patients with sleep-waking rhythm disorders (such as night work…)
  • Patients under trusteeship or guardianship or safeguarding of justice

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Clermont-Ferrand

Clermont-Ferrand, 63003, France

Location

MeSH Terms

Conditions

Parkinson DiseaseRestless Legs SyndromeDisruptive, Impulse Control, and Conduct Disorders

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersParasomniasMental Disorders

Study Officials

  • Ana MARQUES

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
no masking
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: the 2 groups (patients with Parkinson disease with and without RLS) received the same intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2019

First Posted

January 28, 2019

Study Start

January 21, 2019

Primary Completion

June 16, 2022

Study Completion

June 22, 2023

Last Updated

July 10, 2023

Record last verified: 2023-07

Locations